LSIPR webinar: No end in sight for CRISPR IP saga, says HGF

Press releases in recent months that suggest the CRISPR IP saga is about to end are too optimistic and miss out many of the nuances of the current situation, according to Claire Irvine, partner at HGF.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Federal Circuit sides with Broad Institute in CRISPR clash

11 September 2018 The US Court of Appeals for the Federal Circuit handed a win to the Broad Institute of Harvard and MIT yesterday, after finding that the research institute is entitled to some patents covering CRISPR technology.

Biotechnology

CRISPR tech market to reach $1.72m by 2023: report

23 November 2018 The global CRISPR technology market is expected to reach $1.72 million in value by 2023, up from 2018’s predicted figure of $562 million, according to a report released this month.

More on this story

Biotechnology

CRISPR tech market to reach $1.72m by 2023: report

23 November 2018 The global CRISPR technology market is expected to reach $1.72 million in value by 2023, up from 2018’s predicted figure of $562 million, according to a report released this month.

Americas

Federal Circuit sides with Broad Institute in CRISPR clash

More on this story

Biotechnology

CRISPR tech market to reach $1.72m by 2023: report

23 November 2018 The global CRISPR technology market is expected to reach $1.72 million in value by 2023, up from 2018’s predicted figure of $562 million, according to a report released this month.

Americas

Federal Circuit sides with Broad Institute in CRISPR clash